2m 2m 2m 2m 2m 2m 2m
BIOAGE LABS (BIOA)
NASDAQ
$10.43+$1.39 (+15.32%)
Price as of Aug 03, 2026 3:22 PM EDT- $401.9MMarket Cap
- 119.42%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOAGE LABS (BIOA)
$10.43+$1.39 (+15.32%)
BIOA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.04 | ||
Change | -$15.81 (-63.62%) | ||
Open | $8.77 | ||
High | $10.81 | ||
Low | $8.65 | ||
Previous Close | $24.85 | ||
Volume | 9,979,965 | ||
30-Day Average Volume | 1,009,428 | ||
1-Week Change | -58.47% | ||
1-Month Change | -63.12% | ||
1-Year Change | 119.42% | ||
3-Year Change | 5,553.53% | ||
5-Year Change | 5,553.53% | ||
Fundamentals | |||
Shares Outstanding | 44.5M | ||
Total Assets | $397.7M | ||
Market Cap | $401.9M | ||
Enterprise Value | $161.2M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$22.3M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$22.2M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $376.0M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 58 | ||
P/B | 1 | ||
P/E | -17 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue